·The first gastric mucolytic agent in China, enhancing the clarity of the endoscopic field of view ·Recommended in 17 domestic and international guidelines and consensuses ·Honored with awards such as "China Pharmaceutical Product with Significant Clinical Advantages" and the "Second Prize of the Beijing Science and Technology Progress Award"

*For contraindications and adverse reactions, please see the package insert

·Monotherapy for signs and symptoms of early idiopathic Parkinson's disease, or combined with levodopa for all disease stages

*For contraindications and adverse reactions, please see the package insert

·The first domestic-made biological product in the recombinant human coagulation factor Ⅶa category in China ·The first recombinant human coagulation factor Ⅶa whose efficacy and safety have been confirmed through Phase Ⅲ clinical trials in the Chinese population ·It possesses independently developed technologies for cell culture, separation and purification, and formulation with independent intellectual property rights, with two original patents granted

*For contraindications and adverse reactions, please see the package insert